Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Sierra Oncology
company
About
Sierra Oncology is a clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients.
- 101 - 250
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $59.50M
- Industries
- Biotechnology,Health Care,Life Science,Therapeutics
- Founded date
- Jan 1, 2004
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. The company harnesses its deep scientific expertise to identify compounds that target the root cause of disease. Sierra Oncology's team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$59.50M
Sierra Oncology has raised a total of
$59.50M
in funding over 2 rounds. Their latest funding was raised on
Apr 21, 2014 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 21, 2014 | Series D | $59.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Sierra Oncology is funded by 1 investors.
The Amherst Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
The Amherst Fund
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
